One day early vs two days early: where the risk threshold sits The safety calculation changes as you move further from your scheduled day: One day early (day 6 of 7): Blood level difference: approximately 7% higher than intended trough Side effect risk: minimal increase Efficacy impact: none Clinical recommendation: safe for one-time adjustment Two days early (day 5 of 7): Blood level difference: approximately 15% higher than intended trough Side effect risk: modest increase, especially if you're already experiencing nausea Efficacy impact: none Clinical recommendation: acceptable if unavoidable (travel, medical procedure), but not ideal for routine adjustment Three or more days early (day 4 or earlier): Blood level difference: 25%+ higher than intended trough Side effect risk: significant increase in nausea, vomiting, diarrhea Efficacy impact: none, but tolerability suffers Clinical recommendation: contact your provider before dosing The threshold between "safe" and "risky" sits between days 5 and 4

The time of day is flexible, as it is a subcutaneous injection and absorption is not influenced by food intake
Clment K, van dan Akker E, Gordon G, Yuan G, Khnen P
Bullous, Pustular, and Ulcerative Reactions Bullous pemphigoid (BP) is an autoimmune bullous disorder caused by the production of antibodies against hemidesmosomal proteins, primarily BP180 and BP230, which are essential for the adhesion of the epidermis to the dermis